In vitro and in vivo loss of MAFG in hepatocytes controls glucose production, improves glucose metabolism during obesity, and induces lncRNAs, whereas MAFG gain of function represses hepatic lncRNAs. This evidence concerns the gene MAFG and obesity due to melanocortin 4 receptor deficiency.